Meridianin C is a marine natural product known for its anti-cancer activity. At present, the anti-tumour effects of meridianin C on oral squamous cell carcinoma are unknown. Here, we investigated the effect of meridianin C on the proliferation of four different human tongue cancer cells, YD-8, YD-10B, YD-38 and HSC-3. Among the cells tested, meridianin C most strongly reduced the growth of YD-10B cells; the most aggressive and tumorigenic of the cell lines tested. Strikingly, meridianin C induced a significant accumulation of macropinosomes in the YD-10B cells; confirmed by the microscopic and TEM analysis as well as the entry of FITC-dextran, which was sensitive to the macropinocytosis inhibitor amiloride. SEM data also revealed abundant long and thin membrane extensions that resemble lamellipodia on the surface of YD-10B cells treated with meridianin C, pointing out that meridianin C-induced macropinosomes was the result of macropinocytosis. In addition, meridianin C reduced cellular levels of Dickkopf-related protein-3 (DKK-3), a known negative regulator of macropinocytosis. A role for DKK-3 in regulating macropinocytosis in the YD-10B cells was confirmed by siRNA knockdown of endogenous DKK-3, which led to a partial accumulation of vacuoles and a reduction in cell proliferation, and by exogenous DKK-3 overexpression, which resulted in a considerable inhibition of the meridianin C-induced vacuole formation and decrease in cell Nam-Sook Park and Yu-Kyung Park contributed equally to this work.
| INTRODUCTION
Oral squamous cell carcinoma (OSCC) is the most common malignant tumour of the lip, oral cavity and oropharynx. Moreover, OSCC can be severely disfiguring leading to a poor quality of life, including loss of general cognitive, social, emotional or physical functions as well as social relationships. 1 The primary treatment of OSCC is surgical removal, but radiation therapy and/or chemotherapy have emerged as alternative treatment options for OSCC.
2-4
Characteristically, OSCC cells at the late stage of malignancies are very resistant to cancer therapy-mediated apoptosis. Thus, there is an urgent need for understanding resistance mechanism and identifying new drugs or substances which offer therapeutic efficacy against OSCC.
Macropinocytosis is an endocytic pathway that leads to the formation of single membrane irregular vesicles (macropinosomes) by the internalization of large patches of the plasma membrane along with associated extracellular fluid and solutes. 5 Unlike the canonical and endocytic pathways that depend on coat proteins such as clathrin or caveolin, one of the distinctive hallmarks of macropinocytosis is the formation of expansive membrane ruffles within the plasma membrane. 6 This membrane ruffling is initiated by the rapid polymerization of branching of actin filaments. 7 Multiple proteins and signalling factors are involved in macropinocytosis, including the Rho superfamily of GTPases (Rac, Cdc42), lipid components (phosphoinositides, cholesterol, phosphatidylinositol phosphates), phospholipid kinases, receptor tyrosine kinases and phosphatases, SNX-5 and DKK-3. [8] [9] [10] [11] [12] [13] [14] [15] [16] There is also large body of evidence that now shows macropinocytosis can be specifically activated by extracellular stimuli, such as growth factors and natural or synthetic chemicals, and the activated macropinocytosis can have effects on cell survival/proliferation or cell death/growth inhibition on distinct cell types including cancer cells. 17, 18 Meridianin C is one of the marine derived indole alkaloids (meridianin A-G) isolated from the South Atlantic tunicate Aplidium meridianum. 19, 20 Previously, meridianin C, D or G analogues/derivatives have been shown to inhibit the proliferation of human breast (MCF-7) and cervix (HeLa) cancer and leukaemia (MV4-11) cells. [21] [22] [23] At present, neither the anti-tumour effect nor the mode of action of meridianin C in OSCC is known. In this study, we investigated the effect of meridianin C at 1 μM concentration on growth of four different human oral carcinoma cell lines (YD-8, YD-10B, YD-38 and HSC-3) that were originated from tongue (YD-8, YD-10B, HSC-3) or lower gingiva (YD-38). 24 It is worth noting that YD-8 and YD-38 cells have no tumorigenicity, but YD-10B cells are highly tumorigenic and invasive/metastatic. 25, 26 In this article, we report for the first time that meridianin C strongly inhibits the growth of YD-10B OSCC cells through macropinocytosis, and its growth inhibitory and macropinocytosis inducing effects on the cells are mediated in part via the reduced expression of DKK-3. heat-inactivated foetal bovine serum (FBS), 100 units/mL penicillin and 100 μg/mL streptomycin and maintained at 37°C in a humidified condition of 95% air and 5% CO 2 . Meridianin C was synthesized as previously described 23 and prepared as a 10 mM stock solution in DMSO. RPMI-1640 (LM011-01), FBS (S001-01) and penicillin-streptomycin (LS202-02) were purchased from Welgene (Deagu, Republic of Korea). All commercial antibodies and chemicals were purchased from the following resources: anti-procaspase-9
| MATERIAL AN D METHODS

| Cell culture and reagents
(ADI-AAM-139) was from Enzo (Farmingdale, NY, USA); anti-PARP 
| Scanning electron microscopy
YD-10B cells were seeded in 6-well plates (0.5 × 10 6 cells/2 mL/ well) the day before meridianin C treatment. Cells were then treated with vehicle control (DMSO) or 1 μM meridianin C for 2 h.
The conditioned cells were centrifuged, fixed in 0.5% glutaraldehyde and 0.5% paraformaldehyde fixative, washed with 0.1 M phosphate-buffered saline (PBS), and post-fixed with 1% osmium tetroxide solution for 1 h. 2% tannic acid was used to conductively stain for 12 h, later washed with PBS, and fixed with 1% osmium tetroxide solution for 1 h. The specimens were dehydrated with ethanol, t-butyl alcohol and freeze dryer. Finally, the specimen was sputter coated with platinum-palladium (Pt-Pd) in an ion coater for 2 min, followed by microscopic examinations (S-4200, Hitachi Co., Tokyo, Japan). 
| Fluorescein isothiocyanate (FITC) staining
To monitor the functionality of meridianin C-induced macropinocytosis (macropinosome formation/internalization), 0.25 × 10 5 YD-10B cells/mL were seeded on coverslips and treated with meridianin C
(1 μM) and/or FITC-dextran (0.5 mg/mL) in the presence or absence of amiloride (4 mM) for 4 h. The cells were washed twice with PBS and mounted onto microscopic glass slides using Permafluor aqueous mounting media (Thermo Scientific, Waltham, MA, USA) media.
Bright field and fluorescence were observed using a Zeiss AxioObserver.A1 inverted microscope (Carl Zeiss, Germany) and images acquired using Zen 2 software (Carl Zeiss). Fluorescent intensity was quantified using Image-J software.
| Preparation of whole cell lysates
To see the effect of meridianin C on expression of apoptosis-or macropinocytosis-related proteins, YD-10B cells (0.5 × 10 6 /2 mL/ well) were seeded in 6-well plates the day before meridianin C treatment. Cells were treated with meridianin C (1 μM) or vehicle control (DMSO) for the indicated times. At each time-point, cells were washed twice with PBS and proteins extracted using a modified RIPA buffer (50 mM Tris-Cl (pH 7.4), 150 mM NaCl, 0.1% sodium dodecyl sulphate, 0.25% sodium deoxycholate, 1% Triton X-100, 1%
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Nonidet P-40, 1 mM EDTA, 1 mM EGTA, PIC (1×)). The cell lysates were collected and centrifuged at 12 000 rpm for 20 min at 4°C.
The supernatants were saved and protein concentrations determined by bicinchoninic acid assay (BCA) protein assay (Pierce).
| Immunoblot analysis
Proteins ( 
| Generation of stable YD-10B cells overexpressing DKK-3
The pcDNA3.1-DKK3-C-Flag or mock vector was constructed as reported previously. 27 Briefly, YD-10B cells were transfected in a stable manner with the pcDNA3.1-DKK-3-Flag or mock vector using LipofectAMINE transfection reagent as prescribed by the manufacturer (Invitrogen, Carlsbad, CA, USA). After 48 h of incubation, transfected cells were selected in primary cell culture medium containing 200 μg/mL G418 (Promega, Madison, WI, USA). After 2 or 3 weeks, to rule out the possibility of clonal differences between the generated stable cell lines, the pooled YD-10B/mock vector and YD-10B/ DKK-3-Flag clones were tested for DKK-3 and Flag expression by immunoblotting and were used in this study.
| Statistical analyses
Cell count analysis was performed in triplicates and repeated three times. Data were expressed as mean ± SEM. The significance of difference was determined by one-way ANOVA (Laerd Statistics, Chicago, IL, USA). All significance testing was based upon a P < 0.05.
| RESULTS
| Meridianin C has strong growth inhibitory and vacuole-inducing effects on YD-10B cells
We investigated the treatment effect of meridianin C ( Figure 1A 
| Meridianin C-induced macropinocytosis (macropinosome formation/internalization) in YD-10B cells is functional
Amiloride inhibits macropinocytosis by blocking the activity of Na/H exchanger, causing a decrease in pH at the plasma membrane. 30 This amiloride-induced pH drop suppresses the membrane ruffling and membrane extensions that form the macropinosome. 31 Soluble sugars or proteins, such as dextran or albumin, are useful fluorescent markers specific for macropinocytosis. 32 Using amiloride and fluores- 
| Meridianin C-induced down-regulation of DKK-3 protein in YD-10B cells
DKK-3 plays a role in modulating macropinocytosis in T24 human
bladder cancer cells 16 and is also expressed in OSCC-derived cell lines. 33 We therefore sought to explore whether DKK-3 is expressed in YD-10B cells and is regulated by meridianin C treatment. As shown in Figure 5A , high cellular levels of DKK-3 protein were seen in YD-10B cells, and its expression level was even higher relative to Importantly, while meridianin C treatment largely induced many vacuoles in YD-10B mock cells, it had no effect on the formation of vacuoles in YD-10B DKK-3 cells ( Figure 7B) . Furthermore, as shown in Figure 7C , the meridianin C-induced reduction in YD-10B cell survival was considerably blocked by DKK-3 overexpression. 
| Comparison of the effects of meridianin C and its derivatives on growth and macropinosome (vacuole) accumulation in YD-10B cells
We have recently synthesized a novel series of meridianin C derivatives substituted at C-5 position (7a-j) and reported their anti- Data are mean ± SEM of three independent experiments, each performed in triplicate. *P < 0.05 compared to the value of control siRNA at the indicated time proliferative activities against human leukaemic cell lines. 23 In this study, we tested these meridianin C derivatives on growth and We have recently synthesized a series of meridianin C derivatives, and demonstrated their anti-proliferative activity in human leukaemia cell lines including MV4-11. 23 In the current study, we further compared the growth inhibitory and/or macropinocytosis inducing effects of meridianin C and its derivatives on YD-10B cells.
Although some of meridianin C derivatives had macropinocytosis inducing and growth inhibitory effects on YD-10 cells, it was evident that their effects were much weaker than those induced by its parental compound meridianin C. These results indicate that meridianin C has a unique structural moiety leading to strong growth suppressive and macropinocytosis inducing activity in YD-10B cells, which is distinct from other cancer cells.
In summary, meridianin C induces a significant level of macropinocytosis and selectively decreases the survival of YD-10B cells in part through a reduction in DKK-3. Although there are still important issues that remain to be resolved, including meridianin C's macropinocytosis inducing and anti-tumour effects on animal models, our findings suggest that meridianin C is a potential novel target for metastatic human tongue cancer.
